Pfizer explores sale of hospital drugs unit, sources say
Exclusive: Pfizer explores sale of hospital drugs unit, sources say
Pfizer is exploring the sale of its hospital drugs unit, as the drugmaker, which has been under pressure from activist investor Starboard Value, looks to divest non-core assets, according to three people familiar with the matter.
Pfizer (PFE) has been on a downward spiral lately with significant selling pressure. After declining 11% over the past four ...
After a series of acquisitions and an activist investor’s accusation of overspending, Pfizer is exploring an opportunity to ...
Pfizer, a multinational pharmaceutical and biotechnology corporation, is now a $159 billion (by market cap) healthcare giant.
Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...
Centessa had recently conducted an interim analysis of a phase 2 study of its drug, called SerpinPC, which is designed to ...
Pfizer has a pill it's developing called danuglipron, which is in early-stage trials but has demonstrated that it's ...
Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...
Pfizer's stock underperforms the S&P 500, facing patent expirations and competition, yet offers a 6.3% forward dividend yield. Despite a positive Q3 earnings surprise, profitability remains weaker ...
Keurig Dr Pepper brings in Drew Panayiotou to accelerate digital marketing and Andrew Springate takes a new role.
Recent health news highlights include Amgen addressing bone density concerns, AstraZeneca revising its financial outlook ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback